These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1031938)

  • 1. Myocardial fatty acid and cardiac performance.
    Takenaka F; Takeo S
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():379-84. PubMed ID: 1031938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart triglyceride and glycogen metabolism: effects of catecholamines, dibutyryl cyclic AMP, theophylline, and fatty acids.
    Crass MF
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():275-90. PubMed ID: 4377600
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of isoproterenol on myocardial lipid metabolism in rat hearts perfused with and without exogenous substrates.
    Takenaka F; Takeo S
    J Mol Cell Cardiol; 1976 Dec; 8(12):925-40. PubMed ID: 1018326
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in fatty acid composition of cardiac lipids accompanying myocardial necrosis.
    Gudbjarnason S; Oskarsdóttir G
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():193-203. PubMed ID: 1197881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of isoproterenol on the metabolism of myocardial fatty acids.
    Al Makdessi S; Andrieu JL; Herilier H; Faucon G
    J Mol Cell Cardiol; 1987 Feb; 19(2):141-9. PubMed ID: 3573044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium.
    Blasig IE; Blasig R; Löwe H
    Biomed Biochim Acta; 1984; 43(8-9):S171-4. PubMed ID: 6440536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between fatty acid mobilization and contractility in the isolated, perfused rat heart.
    Stam H; Hülsmann WC
    Biochem Biophys Res Commun; 1978 May; 82(2):609-14. PubMed ID: 666863
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats.
    Anandan R; Mathew S; Sankar TV; Viswanathan Nair PG
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):153-8. PubMed ID: 17275273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of triglyceride metabolism in the isotopically prelabeled perfused heart.
    Crass MF
    Fed Proc; 1977 Jun; 36(7):1995-9. PubMed ID: 193738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of catecholamines on myocardial endogenous substrates and contractility.
    Crass MF; Shipp JC; Pieper GM
    Am J Physiol; 1975 Feb; 228(2):618-27. PubMed ID: 1119582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of physiological insulin concentration and depletion on the metabolism of glucose, endogenous glycogen, and triglycerides in the isolated perfused heart.
    Sultan AM; Khan ZA
    Biochem Cell Biol; 1997; 75(3):183-90. PubMed ID: 9404637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial uptake of circulating triglycerides in nondiabetic patients with heart disease.
    Nelson RH; Prasad A; Lerman A; Miles JM
    Diabetes; 2007 Feb; 56(2):527-30. PubMed ID: 17259402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in myocardial & aortic lipids, lipolytic activity & fecal excretion of sterols & bile acids in isoproterenol-induced myocardial infarction in rats.
    Mathew S; Menon PV; Kurup PA
    Indian J Biochem Biophys; 1981 Apr; 18(2):131-3. PubMed ID: 7309083
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
    Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erucic acid-induced alteration of cardiac triglyceride hydrolysis.
    Stam H; Geelhoed-Mieras T; Hülsmann WC
    Lipids; 1980 Apr; 15(4):242-50. PubMed ID: 7374377
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of starvation and of cold stress on clearing factor lipase activity and triglyceride fatty acid utilization in rat heart.
    Rogers MP; Borensztajn J; Robinson DS
    Biochem Soc Symp; 1972; (35):83-92. PubMed ID: 4680246
    [No Abstract]   [Full Text] [Related]  

  • 19. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominance of lipid metabolism in the myocardium under the influence of 1-norepinephrine.
    Regan TJ; Moschos CB; Oldewurtel HA; Weisse AB; Asokan SK
    J Lab Clin Med; 1967 Aug; 70(2):221-8. PubMed ID: 6029054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.